Knight Therapeutics(TSE:GUD)
CA$12.03+0.05 (+0.42%)
TSE:GUD
Knight Therapeutics ownership
CA$12.03
At close:+0.05 (+0.42%)
Want to see TSE:GUD full AI Analyst Report?
Knight Therapeutics (GUD) Ownership - Who Owns Knight Therapeutics?
112 Followers
Knight Therapeutics (GUD) Ownership Overview
- 23.43% Insiders
- 3.80% Mutual Funds
- 0.09% Other Institutional Investors
- 0.96% ETFs
- 71.72% Public Companies and Individual Investors
The ownership structure of Knight Therapeutics (TSE:GUD) stock is a mix of institutional, retail, and individual investors. Approximately 4.85% of the company’s stock is owned by Institutional Investors, 23.43% is owned by Insiders, and 71.72% is owned by Public Companies and Individual Investors.
The ownership structure of Knight Therapeutics (TSE:GUD) stock is a mix of institutional, retail, and individual investors. Approximately 4.85% of the company’s stock is owned by Institutional Investors, 23.43% is owned by Insiders, and 71.72% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Jun 10, 2026 | Melanie Groleau | C$450,558 | |
| May 14, 2026 | Robert Nathaniel Lande | C$335,800 | |
| Apr 14, 2026 | Michael Joseph Tremblay | C$151,600 | |
| Mar 30, 2026 | Santos Dias, Henrique José Dos | C$50,247 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Jonathan Ross Goodman | 21,840,367 | Insider | 22.23% | 184,354,538 |
| Dfa Investment Dimensions Group Inc | 1,546,558 | Institution | 1.57% | 13,054,496 |
| Artisan Partners Funds Inc. | 1,390,451 | Institution | 1.42% | 11,736,797 |
| Dimensional | 671,179 | Institution | 0.68% | 5,665,422 |
| Clearwater Investment Trust | 534,840 | Institution | 0.54% | 4,514,584 |
| Samira Sakhia | 451,034 | Insider | 0.46% | 3,807,178 |
| Old Westbury Funds Inc | 246,614 | Institution | 0.25% | 2,081,669 |
| Robert Nathaniel Lande | 203,178 | Insider | 0.21% | 1,715,025 |
| Amal Khouri | 201,316 | Insider | 0.20% | 1,699,308 |
| Arvind Utchanah | 118,689 | Insider | 0.12% | 1,001,854 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Dfa Investment Dimensions Group Inc | 1,546,558 | Institution | 1.57% | 13,054,496 |
| Artisan Partners Funds Inc. | 1,390,451 | Institution | 1.42% | 11,736,797 |
| Clearwater Investment Trust | 534,840 | Institution | 0.54% | 4,514,584 |
| Old Westbury Funds Inc | 246,614 | Institution | 0.25% | 2,081,669 |
| American Century Etf Trust | 6,500 | Institution | <0.01% | 54,867 |
| Sei Institutional International Trust | 5,800 | Institution | <0.01% | 48,958 |
| John Hancock Variable Insurance Trust | 5,400 | Institution | <0.01% | 45,581 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Dimensional International Small Cap Value ETF, DISV ETF | 311,105 | Institution | 0.32% | 2,624,952 |
| Dimensional International Small Cap ETF, DFIS ETF | 137,815 | Institution | 0.14% | 1,162,816 |
| Dimensional International Core Equity 2 ETF, DFIC ETF | 121,814 | Institution | 0.12% | 1,027,807 |
| SPDR S&P International Small Cap ETF, GWX ETF | 104,098 | Institution | 0.11% | 878,328 |
| Avantis International Equity ETF, AVDE ETF | 71,984 | Institution | 0.07% | 607,751 |
| Dimensional World ex U.S. Core Equity 2 ETF, DFAX ETF | 62,345 | Institution | 0.06% | 526,037 |
| IShare SP/TSX SmlCap, TSE:XCS ETF | 50,492 | Institution | 0.05% | 604,894 |
| Dimensional International Core Equity Market ETF, DFAI ETF | 27,086 | Institution | 0.03% | 228,538 |
| 1stAsst MornstrNBkQC, TSE:QXM ETF | 21,045 | Institution | 0.02% | 127,322 |
| Avantis CIBC Canadian Equity ETF Common Units Trust Units, TSE:CACE ETF | 15,676 | Institution | 0.02% | 187,798 |
FAQ
Who Owns Knight Therapeutics (TSE:GUD)?
According to the latest TipRanks data, approximately 4.85% of the company's stock is held by institutional investors, 23.43% is held by insiders, and 71.72% is held by public companies and individual investors.
What percentage of Knight Therapeutics (TSE:GUD) stock is held by institutional investors?
According to the latest TipRanks data, approximately 4.85% of Knight Therapeutics (TSE:GUD) stock is held by institutional investors: 3.80% by mutual funds, 0.96% by ETFs and 0.09% by other institutional investors.
What percentage of Knight Therapeutics (TSE:GUD) stock is held by retail investors?
According to the latest TipRanks data, approximately 71.72% of Knight Therapeutics (TSE:GUD) stock is held by public companies and individual investors.
Who owns the most shares of Knight Therapeutics (TSE:GUD)?
Jonathan Ross Goodman owns the most shares of Knight Therapeutics (TSE:GUD).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
